Will herd immunity curb COVID-19? Not with rampant spread of ‘anti-science, anti-authority, anti-vaccine’ views

| | June 30, 2020
unnamed
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

With government support, three coronavirus vaccines are expected to be studied in large-scale clinical trials in the next three months.

“The best we’ve ever done is measles, which is 97 to 98 percent effective,” said [Anthony] Fauci, the director of the National Institute of Allergy and Infectious Diseases. “That would be wonderful if we get there. I don’t think we will. I would settle for [a] 70, 75% effective vaccine.”

CNN poll last month found one-third of Americans said they would not try to get vaccinated against Covid, even if the vaccine is widely available and low cost.

In an interview [June 16], CNN asked Fauci whether a vaccine with 70% to 75% efficacy taken by only two-thirds of the population would provide herd immunity to the coronavirus.

Related article:  Viewpoint: Anti-vax conspiracy propaganda movement aiming to derail successful rollout of coronavirus vaccines

“No — unlikely,” he answered.

Herd immunity is when a sufficient proportion of a population is immune to an infectious disease, either through prior illness or vaccination, so that spread from person to person unlikely.

Fauci noted that “there is a general anti-science, anti-authority, anti-vaccine feeling among some people in this country — an alarmingly large percentage of people, relatively speaking.”

He said given the power of the anti-vaccine movement, “we have a lot of work to do” to educate people on the truth about vaccines.

“It’s not going to be easy,” he said. “Anyone [who] thinks it will be easy is not facing reality.”

Read the original post

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend